Centinel’s Chairman and CEO, John J. Viscogliosi, attributes the company’s financial success to its lumbar and cervical implants, including the STALIF TT and STALIF C. The company expects to experience continued success after it launches its next generation lumbar device, STALIF MIDLINE, at the International Society for the Advancement of Spine Surgery conference.
Read the company news release about Centinel Spine’s Q1 financial results.
Read other coverage about device company financial results:
– Biomet Announces 3Q Net Loss of $11.6M
– RSB Spine Announces 145% Sales Increase in Q1
– SANUWAVE Health Reports FY 2010 Revenues of $728K, 10.1% Increase
